- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03565588
Manicaland VMMC Uptake Through Behavioural Incentives Trial
Improving Risk Perception and Uptake of Voluntary Medical Male Circumcision (VMMC) With Education Sessions and Conditional Behavioural Incentives
Primary Objective The purpose of this study is to evaluate the impact of an interactive VMMC education session offered by a circumcised health worker and contribution to transport costs for accessing VMMC along with either (1) conditional economic compensation for wages or (2) lottery-based economic incentives on the uptake of VMMC.
Hypothesis VMMC education session offered by a role model - a young male health worker who has been previously benefited from VMMC services in this community - addressing risks of HIV infection, benefits of VMMC, and the fear of pain associated with VMMC, with/without a conditional fixed or lottery-based financial incentives off-setting present-biased preferences, will improve risk perception and increase uptake of VMMC in HIV-negative young men.
Study outcomes The primary outcomes for the study will be risk perception measured in a follow-up survey at 6 months and proportion of men taking up VMMC within 6 months measured through self-reports and matched to program records.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Manicaland, Zimbabwe
- Manicaland Centre for Public Health Research
-
-
Manicaland
-
Bonda, Manicaland, Zimbabwe
- Manicaland Centre for Public Health Research
-
Hobhouse, Manicaland, Zimbabwe
- Manicaland Centre for Public Health Research
-
Honde, Manicaland, Zimbabwe
- Manicaland Centre for Public Health Research
-
Nyanga, Manicaland, Zimbabwe
- Manicaland Centre for Public Health Research
-
Nyazura, Manicaland, Zimbabwe
- Manicaland Centre for Public Health Research
-
Sakubva, Manicaland, Zimbabwe
- Manicaland Centre for Public Health Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Men
- Age 15-29 years
Exclusion Criteria:
- Participants testing HIV-positive at baseline
- Self-reporting have already undergone circumcision
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Education session with fixed incentive
Education sessions offered by a circumcised health worker and contribution towards transport costs to the health facility with payments conditional on being circumcised.
|
All participants will receive an education session on the risk of HIV infection and benefits from medical male circumcision. The sessions will be implemented by trained male healthcare workers who have undergone VMMC. All participants will receive contributions towards transport costs to access medical male circumcision at participating clinics. On completing VMMC, participants assigned to receive fixed incentives will receive payment through mobile payments. In two sites a community-led intervention will also be implemented to address social obstacles and to increase support from peers, families and social structures. |
Experimental: Education session with lottery incentive
Education sessions offered by a circumcised health worker and contribution towards transport costs but with conditional lottery financial incentives.
|
All participants will receive an education session on the risk of HIV infection and benefits from medical male circumcision. The sessions will be implemented by trained male healthcare workers who have undergone VMMC. All participants will receive contributions towards transport costs to access medical male circumcision at participating clinics. On completing VMMC, participants will participate in a lottery with prizes equivalent in expected value to the fixed incentives. In two sites a community-led intervention will also be implemented to address social obstacles and to increase support from peers, families and social structures. |
No Intervention: Control arm
No intervention will be administered to the control arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Uptake of voluntary medical male circumcision (VMMC)
Time Frame: 6 months
|
Proportion of men taking up VMMC within 6 months measured through self-reports and matched to programme records
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in perception of risk of HIV
Time Frame: 6 months
|
Risk perception will be measured in a follow-up survey at 6 months
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Simon Gregson, PhD, Imperial College London
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- Urogenital Diseases
- Genital Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- P67251_VMMC
- 1R01MH114562-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Medical College of WisconsinCompleted
-
Emory UniversityCompleted
-
Rhode Island HospitalUnknown
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Lampiris, Harry W., M.D.AbbottUnknown
Clinical Trials on Education session with fixed incentive
-
University of California, San FranciscoUniversity of California, Los AngelesCompletedDental Caries | Parent-Child Relations | Oral Hygiene | Dental Plaque | ToothbrushingUnited States
-
Imperial College LondonNational Health Service, United KingdomCompletedDiabetes | Diabetic Retinopathy
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed
-
Mayo ClinicCompletedTobacco CessationUnited States
-
National University of SingaporeCompletedHealth Knowledge, Attitudes, Practice | Weight ReductionSingapore
-
Good Samaritan Hospital Medical Center, New YorkRecruiting
-
Tufts UniversityNewman's Own Foundation; Stop & Shop Supermarket Company; Soccer4Success/America...Completed
-
University of NebraskaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Nantes University HospitalTerminated
-
Abant Izzet Baysal UniversityCompleted